WisdomTree BioRevolution Fund (BATS:WDNA) Trading 27.2% Higher – Should You Buy?

Posted by Patrick Bannon on Jan 2nd, 2026

WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) traded up 27.2% during trading on Wednesday . The company traded as high as $13.1350 and last traded at $16.8750. 465 shares traded hands during trading, a decline of 51% from the average session volume of 948 shares. The stock had previously closed at $13.2623.

WisdomTree BioRevolution Fund Stock Up 27.2%

The stock has a market cap of $2.53 million, a P/E ratio of 17.03 and a beta of 1.01. The business has a 50-day simple moving average of $17.07 and a 200-day simple moving average of $15.59.

Institutional Investors Weigh In On WisdomTree BioRevolution Fund

A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Jane Street Group LLC grew its holdings in WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,864 shares of the company’s stock after buying an additional 5,306 shares during the period. Jane Street Group LLC owned 11.24% of WisdomTree BioRevolution Fund worth $231,000 at the end of the most recent quarter.

About WisdomTree BioRevolution Fund

(Get Free Report)

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.